| Ytd | 76.49% | |
| 1y | 96.87% |
| Open | 115.04 | Prev Close | 115.07 | Low | 114.99 | High | 115.13 | Mkt Cap | 6.73B |
| Vol | 0.00 | Avg Vol | 1.45M | EPS | -4.07 | P/E | -28.27 | Forward P/E | 61.73 |
| Beta | 0.25 | Short Ratio | 1.56 | Inst. Own | 90.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 112.62 | 200-d Avg | 84.15 | 1yr Est | 112.20 |
ACLX News
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the succe
Here is how Arcellx, Inc. (ACLX) and Astellas Pharma Inc. (ALPMY) have performed compared to their s
Arcellx, Inc. (NASDAQ: ACLX - Get Free Report) has been given an average rating of "Hold" by the nin
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all
Banque Pictet and Cie SA bought a new stake in shares of Arcellx, Inc. (NASDAQ: ACLX) in the fourth
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expira
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves
Cormorant Asset Management sold 775,000 Arcellx shares in the fourth quarter. The fund's quarter-end
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Bamco Inc. NY lifted its holdings in Arcellx, Inc. (NASDAQ: ACLX) by 6.2% during the undefined quart
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Gilead plans a $7.8B Arcellx acquisition as cell therapy sales decline, seeking full control of anit
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde a
Arcellx, Inc. (NASDAQ: ACLX - Get Free Report) has earned an average recommendation of "Hold" from t
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
As of March 4, 2026, two stocks in the health care sector could be flashing a real warning to invest
Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gai
ACLX share prices have soared nearly 75% in 2026 due to the recent announcement that Arcellx will be
Tuesday's session saw 211 companies set new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Tuesday's session saw 52 companies set new 52-week lows.
On Monday, 71 stocks hit new 52-week lows.